Clinical Trials on Alzheimer's Disease Conference (CTAD)

The Clinical Trials on Alzheimer's Disease Conference (CTAD) includes a focus on Alzheimer disease (AD) therapeutic trials, featuring leaders in AD research from industry and academia with an aim of forming partnerships to progress the development of effective treatments to fight the disease.

© 2024 MJH Life Sciences

All rights reserved.